Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2021

Mar 16, 2021

33625_dirs_2021-03-16_7cd05e87-d2d4-429a-9977-20ac7ed1df72.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-03-15

Reporting Person: Myers Byron (EVP, Marketing)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-15 Common Stock M 7102 $16.62 Acquired 44429 Direct
2021-03-15 Common Stock S 4050 $51.7759 Disposed 40379 Direct
2021-03-15 Common Stock S 3052 $52.2137 Disposed 37327 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-15 Stock Option (Right to Buy) $16.62 M 7102 Disposed 2021-03-31 Common Stock (7102) Direct

Footnotes

F1: Represents the weighted average share price of an aggregate total of 4,050 shares sold in the price range of $51.10 to $52.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Represents the weighted average share price of an aggregate total of 3,052 shares sold in the price range of $52.11 to $52.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014.